Dr. Bukola Aminat Oseni
Senior Lecturer
Specialization: Targeted Drug Delivery System Development; Natural Product Formulation Development
Personal Statement
I am a researcher and formulation scientist passionate about providing health solutions to the populace through the development and availability of safe and effective medicines for the treatment of diseases. My research focuses on developing novel targeted delivery systems for new and existing anticancer, anti-infective, and contraceptive medicines utilizing tools in nanotechnology and biotechnology. I am keen on developing medicines from natural products for commercial use. My goal is to make available through collaborative research safe medicines with improved efficacy in the field of contraceptive, cancer, and infection management, with the long-term goal of improving prognosis and contributing to achieving the Sustainable Development Goal of ensuring healthy lives and promoting well-being of the populace. I also participate in enlightening people on the appropriate use of medicines through research and community engagement.
Education / Training
| Institution | Degree | Completion Date | Field of Study |
|---|---|---|---|
| Obafemi Awolowo University | BPharm | 2010 | Pharmacy |
| De Montfort University | M.Sc. | 2013 | Pharmaceutical Biotechnology |
| University of Lagos | PhD | 2021 | Pharmaceutics & Pharmaceutical Technology |
Positions, Scientific Appointments and Honours
- Member of the Editorial Committee, Nigerian Journal of Pharmaceutical Research (March 2025)
- Secretary, Fulbright Alumni Association of Nigeria, Lagos (March 2020 – Present)
- Fulbright Foreign Student Fellowship (Aug 2018 – May 2019 )
- Association of African Universities Grant for thesis and dissertation (July 2017)
- Reviewer (International Journal of Biological Macromolecule)
Selected Most recent Publications/Contributions to knowledge
- Oseni B.A., Osekita S.T., Ibrahim, M.B., Igbokwe, N.H., Azubuike, C.P. (2024). Development of emulgel formulation from Markhamia tomentosa leaf extract: Characterization and in vitro antimicrobial activity against skin isolates. Am J Pharmacother Pharm, 3(1) 1-9.
- Ilomuanya, M.O., Oseni, B.A., Okwuba, B.C., Abia, P., Aboh, M.I., Oluwale, O.P., Alkiviadis, T., Tsouknidas, A.E., Amenaghawon, A.N., Nwaneri, S.C. (2024). Evaluation of MDR-specific phage Pɸ-Mi-Pa loaded mucoadhesive electrospun nanofibrous scaffolds against drug-resistant Pseudomonas aeruginosa- induced wound infections in an animal model. International Journal of Biological Macromolecules, 277, 134484. https://doi.org/10.1016/j.ijbiomac.2024.134484.
- Ilomuanya, M.O., Ogundemuren, D.A., Bassey, PO.O., Oseni, B.A., Kola‑Mustapha, A.T., Tsamos, D., Alkiviadis, T., Tsouknidas, A.E., Amenaghawon, A.N. (2024). Enhanced viability of Lactobacillus spp. via encapsulation in hyaluronan/PVA hybrid electrospun composites for vaginal drug delivery. Futur J Pharm Sci 10 (105). https://doi.org/10.1186/s43094-024-00675-5
- Oseni B.A., Azubuike C.P., Okubanjo O.O., Igwilo C.I., Panyam J. (2021). Encapsulation of Andrographolide in poly(lactide-co-glycolide) Nanoparticles: Formulation Optimization and in vitro Efficacy Studies. Bioeng. Biotechnol. 9:639409. doi:10.3389/fbioe.2021.639409
- Oseni, B.A., Azubuike, C.P., Okubanjo, O.O., Igwilo, C.I. (2020). In Vitro Cytotoxic Effect of Andrographolide on MDA-MB-231-LM2 Breast Cancer Cells and Its Formulation and Characterization as An Emulsion. Trop J Nat Prod Res. 4(1): 1-7. https://doi.org/10.26538/tjnpr/v4i1.1
Collaborations/ Networks
- Jayanth Panyam, University of Washington School of Pharmacy, USA
- Margaret Ilomuanya, Department of Pharmaceutics & Pharmaceutical Technology, University of Lagos
- Mutiat Ibrahim, Department of Pharmacognosy, University of Lagos
- Adeola Kola-Mustapha, Department of Pharmaceutics & Industrial Pharmacy, University of Ilorin
- Mercy Aboh, National Institute of Pharmaceutical Research (NIPRD), Abuja
